Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer
G Schmidt, I Juhasz-Böss, C Gerlinger, A Rody, C Liedtke, E Stickeler, P Wimberger, T Fehm, E Müller, R Bohle, S Stein, EF Solomayer · Geburtshilfe und Frauenheilkunde · 2016 · Heft 10
Bibliografische Angaben
Zusammenfassung
Purpose: Triple-negative breast cancer (TNBC) is characterized by a strong heterogeneity as well in the tumour biology as in the clinical course of disease. This study has the aim to analyse if there are any prognostic factors which are able to predict the individual outcome of patients with TNBC. Main goal of this analysis is to find out if there are any differences with regard to the chances of survival between patients with TNBC and a Her2-neu score 0 versus 1+2. Experimental Design: Retrospectively, we studied a cohort of 1013 patients with TNBC, diagnosed at seven hospitals between May 2002 and February 201…